<html>
<head>PUBMED IDs for CTNNBIP1</head>
<body bgcolor='#C5F0F2'><h1>CTNNBIP1</h1><a href='https://pubmed.ncbi.nlm.nih.gov/17044048/'>Neuroblastoma tumors with favorable and unfavorable outcomes: Significant differences in mRNA expression of genes mapped at 1p36.2.</a> October 18  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/18795334/'>Apparent autosomal dominant keratoconus in a large Australian pedigree accounted for by digenic inheritance of two novel loci.</a> September 17  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19530245/'>WNT/beta-catenin pathway activation in Wilms tumors: a unifying mechanism with multiple entries?</a> October 3  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/22505352/'>Clinically significant copy number alterations and complex rearrangements of MYB and NFIB in head and neck adenoid cystic carcinoma.</a> November 6  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/24390805/'>Effects of genistein and daidzein on cell proliferation kinetics in HT29 colon cancer cells: the expression of CTNNBIP1 (β-catenin), APC (adenomatous polyposis coli) and BIRC5 (survivin).</a> September 26  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25175916/'>MiR-424-5p reversed epithelial-mesenchymal transition of anchorage-independent HCC cells by directly targeting ICAT and suppressed HCC progression.</a> October 17  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25175909/'>ERG and CHD1 heterogeneity in prostate cancer: use of confocal microscopy in assessment of microscopic foci.</a> February 13  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25175907/'>MicroRNA-708 regulates CD38 expression through signaling pathways JNK MAP kinase and PTEN/AKT in human airway smooth muscle cells.</a> April 18  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25681036/'>miR-603 promotes glioma cell growth via Wnt/β-catenin pathway by inhibiting WIF1 and CTNNBIP1.</a> July 15  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25681031/'>[Aquagenic palmar keratoderma in a patient heterozygous for the mutation c.3197G&gt;C in the CFTR gene].</a> December 29  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26317904/'>MiR-215, an activator of the CTNNBIP1/β-catenin pathway, is a marker of poor prognosis in human glioma.</a> July 20  2015<br></body></html>
